carvacrol has been researched along with Colonic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arigesavan, K; Sudhandiran, G | 1 |
Cao, Y; Fan, K; Li, L; Li, X; Qi, H; Sun, H; Zhang, Q | 1 |
Arivalagan, S; Chandrasekaran, B; Kuppsamy, T; Mani, V; Namasivayam, N; Siddique, AI; Thomas, NS | 1 |
3 other study(ies) available for carvacrol and Colonic Neoplasms
Article | Year |
---|---|
Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Colitis; Colon; Colonic Neoplasms; Cymenes; Dextran Sulfate; Interleukin-1beta; Male; Mast Cells; Monoterpenes; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344 | 2015 |
Carvacrol inhibits proliferation and induces apoptosis in human colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Cymenes; Extracellular Signal-Regulated MAP Kinases; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Monoterpenes; Neoplasm Invasiveness; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2 | 2015 |
Combined therapeutic efficacy of carvacrol and X-radiation against 1,2-dimethyl hydrazine-induced experimental rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Antigens, Nuclear; Antineoplastic Agents; Chemoradiotherapy; Colonic Neoplasms; Cymenes; Drug Administration Schedule; Enzymes; Male; Mast Cells; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Monoterpenes; Mucins; Neoplasms, Experimental; Radiation Dosage; Rats, Wistar; Time Factors | 2015 |